UnitedHealth Group Incorporated (NYSE:UNH) shares rose more than 5% on Friday following the company’s Q2 results, with EPS of $5.57 coming in better than the Street estimate of $5.21. Revenue was $80.3 billion, compared to the Street estimate of $79.68 billion. Overall, the strong results highlight the company’s positioning despite an unpredictable and volatile economic backdrop. Due to the beat, the company raised its full 2022-year guidance to $21.40—21.90 from $21.20—21.70.
Analysts at Oppenheimer raised their 2022/2023/2024 EPS estimates to $21.88/$24.80/$28.03 from $21.68/$24.54/$27.84 following the results. The analysts also increased their price target on the company’s shares to $610 from $600, while reiterating their outperform rating.
At CWEB, we are always looking to expand our network of strategic investors and partners. If you're interested in exploring investment opportunities or discussing potential partnerships and serious inquiries. Contact: jacque@cweb.com